United States · FDA National Drug Code directory
Lapatinib
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42291-035_302a4314-e1d6-3ce6-e063-6394a90a75a1
- Product NDC
- 42291-035
- Form
- TABLET, FILM COATED
- Composition / generic term
- Lapatinib
- Labeler
- AvKARE
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250312
- Source listing expiry
- 20261231
Source-listed ingredients
- LAPATINIB DITOSYLATE — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 150 TABLET, FILM COATED in 1 BOTTLE (42291-035-15) · 42291-035-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →